BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Immunoglobulin Idiotypes

Below is an extended Immunoglobulin Idiotypes research listing. Click here to return to the Immunoglobulin Idiotypes main in depth entry.

Recent Publications on Immunoglobulin Idiotypes:

Role of natural antibodies in immune homeostasis: IVIg perspective.
Intravenous immunoglobulin (IVIg) has increasingly been used for the...
Direct Link
30th August, 2008
Centre de Recherche des Cordeliers, Equipe 16 - Immunopathology and
What is the contents of the magic draft IVIg?
Intravenous immunoglobulins (IVIg) consist of IgG concentrated from pooled...
Direct Link
30th August, 2008
Immunology and Pathology Research Unit, Medical School, Brest, France.
Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study.
Plant-made vaccines have been the subject of intense interest because they...
Direct Link
20th August, 2008
Large Scale Biology Corporation, 3333 Vaca Valley Parkway, Vacaville, CA
Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
A specific immune response against the individual idiotypic determinants...
Direct Link
20th August, 2008
Department of Immunology, Hospital Clinica Puerta de Hierro, Madrid,
Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC).
BACKGROUND: Circulating myeloma cells (CMC), exhibiting the same...
Direct Link
22nd July, 2008
Immune and Gene Therapy Laboratory, Cancer Centre Karolinska, Stockholm,
Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
Immunoglobulins are expressed as membrane-bound or secreted forms. Plasma...
Direct Link
19th July, 2008
Department of Human Microbiology, Sackler School of Medicine, Tel Aviv
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination.
An ideal vaccination strategy against tumors relies on specific antigens...
Direct Link
12th July, 2008
Center for Experimental Research and Medical Studies, University of
A common idiotype in IgE and its relation to recognition of the grass pollen allergen Phl p 2.
The variable regions of allergen-specific IgE, the isotype mediating...
Direct Link
8th July, 2008
Department of Immunotechnology, Lund University, BMC D13, SE-221 84 Lund,
Boosting anti-idiotype immune response with recombinant AAV enhances tumour protection induced by gene gun vaccination.
Thanks to the safety of administration, efficiency of in vivo transduction...
Direct Link
2nd July, 2008
ICGEB-International Centre for Genetic Engineering and Biotechnology,
DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. 20th June, 2008
Department of Microbiology, University of Alabama at Birmingham,
[From the allergen-recognition by antibodies to new therapeutic concepts]
Cross-linking of IgE antibodies through allergens is a basic event in type...
Direct Link
31st May, 2008
Center fur Physiologie und Pathophysiologie der Medizinischen Universitat
Clinical benefit of idiotype vaccines: too many trials for a clever demonstration? 16th May, 2008
Center for Applied Medical Research, University of Navarre, Avda. Pio XII
The immunoglobulin constant region contributes to affinity and specificity.
A central dogma in immunology is that antibody specificity is solely the...
Direct Link
7th May, 2008
Department of Microbiology and Immunology, Albert Einstein College of
Gender dichotomy in antibody response in a T-cell lymphoma: involvement of IL-13 and gonadal hormones.
PROBLEM: Dalton's lymphoma (DL) shows very high interleukin (IL)-13 level...
Direct Link
16th April, 2008
Immunology Laboratory, Department of Zoology, Faculty of Science, Banaras
HLA class II-like antiidiotypic antibodies from highly sensitized patients inhibit T-cell alloresponses.
The purpose of this study is to identify factors in the sera of highly...
Direct Link
20th February, 2008
Toronto Western Research Institute, University Health Network, Toronto,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional